Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FP63L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,080
Award facts
- Contract value 100% obligated
- $10,080.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,080.42 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count) under a firm fixed price contract. The award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. Vraylar is a psychiatric medication used to treat conditions such as bipolar disorder and schizophrenia, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical products for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply diverse pharmaceutical products and medical commodities to military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering medications across multiple therapeutic domains, including specialty drugs, vaccines, and medical supplies for defense and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FP63L?
SPE2DB25FP63L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FP63L worth?
The government has obligated $10,080 on SPE2DB25FP63L.
Is contract SPE2DB25FP63L an order under another contract?
Yes. SPE2DB25FP63L is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP63L competed?
The extent of competition for SPE2DB25FP63L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award